About the Study
Who can participate?
Females ages 55–80 with the Fragile X premutation with or without FXTAS may be eligible to participate.
What will happen in the study?
If the individual qualifies and decides to be in this research study, they will come to the University of Kansas – Lawrence and the University of Kansas Medical Center for 1-2 visits.
Participants will be asked to complete the following study tasks: cognitive testing, clinical neurological evaluation, motor testing, MRI, and a blood draw.
A clinical report may be provided upon request.
What are the good things that can happen from this research?
The goal of this study is to gain a better understanding of the cognitive and motor issues associated with FXTAS and identify markers associated with FXTAS onset.
What are the bad things that can happen from this research?
The potential risks related to testing are minimal, and they are no greater than those experienced through regular clinical evaluations. There may be other risks that we do not know about yet.
Will I or my child be paid to complete this study?
Participants will be compensated for their time. Travel reimbursement may be available for participants.